All Articles

AIoT leader Tuya returns to profitability, proving operational discipline and a robust developer ecosystem can overcome global trade uncertainties.

Beyond the numbers, United Rentals' recent debt refinancing is a strategic move to fortify its market leadership and fund future innovation.

Marten Transport's 62nd straight dividend signals resilience. But what does its performance in cold chain logistics tell us about broader economic health?

CoStar Group's Homes.com is challenging the portal giants with a pro-agent model and new tech. Can its audacious strategy deliver resilient returns?

New survival data for Inluriyo, precision insights for Verzenio, and a next-gen drug signal Lilly's aggressive strategy to dominate HR+ breast cancer.

Specialty materials firm Mativ appoints a culture and transformation expert to its board, signaling a strategic pivot to human capital as a key driver of post-merger growth.

Bed Bath & Beyond's acquisition of The Brand House Collective is a bold play for profitability, aiming for $20M in savings and a new omnichannel strategy.

A routine stock grant at Forte Biosciences reveals a fierce talent war and offers savvy investors a rare glimpse into the high-stakes world of biotech innovation.

With a new lung cancer drug approved and an obesity treatment in the wings, Amgen's investor talk is a key bellwether for biotech's future in Canada.

With a major non-dilutive financing deal, Nanobiotix de-risks its pipeline and expands its nanotechnology platform beyond its lead cancer drug.

Materials giant Westlake hits its 2030 emissions target six years early, raising the bar and signaling a strategic shift for industrial supply chains.

We vet the season's hottest gadgets, from smart vacuums to flip phones, and uncover the sophisticated marketing machine that puts them on your TV screen.

Beyond the stock ticker, Nuvalent's massive capital raise reveals a deeper story about investor confidence, patient hope, and the future of cancer therapy.

Strong earnings driven by AI and 5G show Keysight's pivotal role. A new $1.5B buyback underscores management's bullish outlook for investors and its future.

Central Garden & Pet's sales dipped, but profits soared. Discover how a radical efficiency plan is reshaping the company for a new economic era.

A new service merges branding and interior design, transforming physical spaces from a cost center into a strategic asset for growth and market impact.

PFLT posts strong fiscal year results, launching a new joint venture and acquiring a $250M portfolio to drive future income amid a dynamic market.

A top advisory firm’s new security milestone reveals a critical truth: protecting pharma and biotech IP now depends on the digital defenses of all partners.

As specialists gather, the focus shifts from symptoms to complex systems, targeting obesity and pressure disorders to redefine patient care and outcomes.

After a historic storm, Royalton Hotels' recovery plan reveals a strategy focused on human capital, long-term investment, and Jamaica's resilience.